Vanguard Group
FURX

Vanguard Group’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Vanguard Group’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-236,100
Closed -$25.1M – 4059
2014
Q2 		$25.1M Buy
236,100
+7,662
+3% +$751K ﹤0.01% 2132
2014
Q1 		$19.9M Sell
228,438
-24,615
-10% -$1.9M ﹤0.01% 2180
2013
Q4 		$10.6M Buy
253,053
+936
+0.4% +$38.5K ﹤0.01% 2432
2013
Q3 		$11.1M Sell
252,117
-1,525
-0.6% -$63.1K ﹤0.01% 2353
2013
Q2 		$8.64M Buy
+253,642
New +$8.9M ﹤0.01% 2395

Vanguard Group's FURX Position: Q3 2014 in Review

Vanguard Group sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 236,100 shares — an estimated $25.1M sold.

Vanguard Group first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $25.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Vanguard Group reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Vanguard Group sold 236,100 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $25.1M.
  • Vanguard Group first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Vanguard Group's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $25.1M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Vanguard Group's 13F filing for Q3 2014, filed 12 Nov 2014.